Lupin
As of the edition of 20 October 2026, Lupin runs 10 drugs, 7 of them marketed.
Sources: ClinicalTrials.gov, FDA Orange Book and Purple Book, other approval registers, company records.
Family history
The records place 2 company names in this family.
Drugs by status
| Status | Count |
|---|---|
| Marketed | 7 |
| Went quiet | 1 |
| Status not established | 2 |
| Total | 10 |
Marketed drugs and when their US protection ends
| Drug | US protection | Route B rows |
|---|---|---|
| Fenofibrate | none listed | 3 |
| Pitavastatin | none listed | 1 |
| Levosalbutamol | none listed | 0 |
| Cefixime | none listed | 0 |
| Mexiletine | none listed | 0 |
| Arformoterol | none listed | 0 |
| Fosphenytoin | none listed | 0 |
A route B row is one company at one target.